Skip to main content
. 2016 Mar 22;18(9):1288–1296. doi: 10.1093/neuonc/now044

Fig. 1.

Fig. 1.

Analysis of miR-301a expression and the effect on glioma patient survival. (A) miR-301a expression in glioma and normal brain tissues as detected by quantitative PCR. (B) Kaplan-Meier (KM) survival curves analyzed glioma patients who had high or low expression of miR-301a. (C) KM survival curves analyzed high-grade glioma patients (III–IV) with high or low expression of miR-301a. *P < .01 as compared with normal brain tissues.